Swiss National Bank Acadia Pharmaceuticals Inc Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Swiss National Bank holds 209,204 shares of ACAD stock, worth $3.39 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

209,204

Previous 210,604 0.66%

Holding current value

$3.39 Million

Previous $3.42 Million 5.93%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$15.14 - $19.14 $21,196 - $26,796	-1,400 Reduced 0.66%	209,204 $3.22 Million
Q1 2024 May 07, 2024	BUY	$17.79 - $30.86 $14,232 - $24,688	800 Added 0.38%	210,604 $3.89 Million
Q4 2023 Feb 06, 2024	SELL	$20.78 - $31.77 $469,628 - $718,002	-22,600 Reduced 9.72%	209,804 $6.57 Million
Q3 2023 Nov 08, 2023	SELL	$20.84 - $33.47 $310,516 - $498,703	-14,900 Reduced 6.02%	232,404 $4.84 Million
Q2 2023 Aug 09, 2023	SELL	$17.8 - $25.65 $263,440 - $379,620	-14,800 Reduced 5.65%	247,304 $5.92 Million
Q1 2023 May 10, 2023	SELL	$16.32 - $20.92 $505,920 - $648,520	-31,000 Reduced 10.58%	262,104 $4.93 Million
Q4 2022 Feb 08, 2023	BUY	$14.2 - $18.63 $85,200 - $111,780	6,000 Added 2.09%	293,104 $4.67 Million
Q3 2022 Nov 09, 2022	BUY	$14.11 - $18.27 $28,220 - $36,540	2,000 Added 0.7%	287,104 $4.7 Million
Q1 2022 May 09, 2022	BUY	$20.94 - $27.5 $429,270 - $563,750	20,500 Added 7.75%	285,104 $6.91 Million
Q2 2021 Aug 06, 2021	SELL	$19.4 - $27.42 $151,320 - $213,876	-7,800 Reduced 2.86%	264,604 $6.45 Million
Q1 2021 May 07, 2021	BUY	$25.02 - $54.99 $75,060 - $164,970	3,000 Added 1.11%	272,404 $7.03 Million
Q4 2020 Feb 05, 2021	BUY	$41.04 - $56.79 $184,680 - $255,555	4,500 Added 1.7%	269,404 $14.4 Million
Q3 2020 Nov 09, 2020	BUY	$36.42 - $57.0 $174,816 - $273,600	4,800 Added 1.85%	264,904 $10.9 Million
Q2 2020 Aug 05, 2020	BUY	$39.26 - $52.73 $1.42 Million - $1.9 Million	36,100 Added 16.12%	260,104 $12.6 Million
Q1 2020 May 08, 2020	BUY	$31.65 - $46.87 $522,225 - $773,355	16,500 Added 7.95%	224,004 $9.46 Million
Q4 2019 Feb 06, 2020	BUY	$36.21 - $51.4 $148,461 - $210,740	4,100 Added 2.02%	207,504 $8.88 Million
Q3 2019 Nov 12, 2019	BUY	$22.22 - $44.01 $59,994 - $118,827	2,700 Added 1.35%	203,404 $7.32 Million
Q2 2019 Aug 02, 2019	SELL	$23.32 - $28.12 $118,932 - $143,412	-5,100 Reduced 2.48%	200,704 $5.37 Million
Q1 2019 May 10, 2019	BUY	$16.17 - $27.38 $38,808 - $65,712	2,400 Added 1.18%	205,804 $5.53 Million
Q4 2018 Feb 13, 2019	BUY	$14.32 - $22.92 $429,600 - $687,600	30,000 Added 17.3%	203,404 $3.29 Million
Q1 2018 May 04, 2018	BUY	$22.47 - $32.33 $148,302 - $213,378	6,600 Added 3.96%	173,404 $3.9 Million
Q4 2017 Feb 07, 2018	BUY	$26.84 - $39.14 $104,676 - $152,646	3,900 Added 2.39%	166,804 $5.02 Million
Q3 2017 Nov 03, 2017	BUY	$29.49 - $38.37 $4.8 Million - $6.25 Million	162,904	162,904 $6.14 Million

Others Institutions Holding ACAD

# of Institutions

280

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.62B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Acadia Pharmaceuticals Inc Transaction History